Frontlight ResearchEarly access
Taking people in United StatesPhase 2
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
Key facts
- Who runs it
- University of California, San Francisco
- Where
- San Francisco, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 30 people, planned
- Started
- 7 Aug 2023
- Expected to end
- 30 Apr 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- Burst Suppression EEG Target Intravenous Anesthesia
- Seizure Suppression EEG Target Intravenous Anesthesia
- Record updated
- 29 July 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Age ≥18 years old
- Non-traumatic, out-of-hospital cardiac arrest
- Comatose on admission - defined as not following commands
- Return of spontaneous circulation (ROSC) within less than 45 minutes
- Admission to the intensive care unit
- Diagnosis of post-cardiac arrest refractory status epilepticus confirmed with continuous; EEG monitoring within 7 days from ROSC
Who cannot take part
- Acute cerebral hemorrhage or infarction
- Pregnancy
- Prisoners
This trial is currently available in United States.
- Zuckerberg San Francisco General HospitalSan Francisco, United StatesContact: Edilberto Amorim, MDTaking people
About the trial
What the trial wants to find out
RESTORE is a randomized clinical trial investigating the safety and feasibility of using EEG treatment targets (burst suppression vs. seizure suppression) for post-cardiac arrest refractory status epilepticus treatment.
The 2 groups in the trial
- Burst Suppression EEG TargetOther group
Anesthetic will be titrated to achieve burst suppression on continuous EEG (50-99% attenuation/suppression) for 24 hours.
Treatment: Burst Suppression EEG Target Intravenous Anesthesia
- Seizure Suppression EEG TargetOther group
Anesthetic will be titrated to achieve seizure suppression on continuous EEG for 24 hours.
Treatment: Seizure Suppression EEG Target Intravenous Anesthesia
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest (RESTORE)
- Record updated
- 29 July 2026